NYSE:ELVHealthcare
Elevance Health Weighs Membership Declines Against Strong Returns And Analyst Support
Elevance Health, NYSE:ELV, is seeing a persistent decline in its customer base over the past two years.
This contraction comes while the company reports capital efficient growth and a solid competitive position in its core markets.
The combination of customer losses and operational strength raises questions about competition, product fit, and possible signs of market saturation.
For investors tracking NYSE:ELV, the picture is mixed. The stock trades at $371.06, with a 30 day return of 8.1%...